Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice.
about
Identification of GRIM-19, a novel cell death-regulatory gene induced by the interferon-beta and retinoic acid combination, using a genetic approachBAL1 and BBAP are regulated by a gamma interferon-responsive bidirectional promoter and are overexpressed in diffuse large B-cell lymphomas with a prominent inflammatory infiltrateThe cell death regulator GRIM-19 is an inhibitor of signal transducer and activator of transcription 3STAT1 activation regulates proliferation and differentiation of renal progenitorsNatural selection of tumor variants in the generation of "tumor escape" phenotypesT-bet antagonizes mSin3a recruitment and transactivates a fully methylated IFN-gamma promoter via a conserved T-box half-siteTYK2 is a key regulator of the surveillance of B lymphoid tumorsRegulation of pulmonary fibrosis by chemokine receptor CXCR3Identification of two residues in MCM5 critical for the assembly of MCM complexes and Stat1-mediated transcription activation in response to IFN-gammaAutosomal dominant and sporadic monocytopenia with susceptibility to mycobacteria, fungi, papillomaviruses, and myelodysplasiaCollaboration of signal transducer and activator of transcription 1 (STAT1) and BRCA1 in differential regulation of IFN-gamma target genesCancer immunoediting from immune surveillance to immune escapePathogen-specific loss of host resistance in mice lacking the IFN-gamma-inducible gene IGTPSignal transducers and activators of transcription as regulators of growth, apoptosis and breast development.Challenges to the development of antigen-specific breast cancer vaccines.CAM and NK CellsRevisiting immunosurveillance and immunostimulation: Implications for cancer immunotherapyJanus kinases and signal transducers and activators of transcription: their roles in cytokine signaling, development and immunoregulation.A Bitter Sweet Symphony: Immune Responses to Altered O-glycan Epitopes in CancerNovel cancer antigens for personalized immunotherapies: latest evidence and clinical potentialControl of CD8 T-Cell Infiltration into Tumors by Vasculature and MicroenvironmentTargeting caspases in cancer therapeuticsBeneficial autoimmunity at body surfaces - immune surveillance and rapid type 2 immunity regulate tissue homeostasis and cancerSTAT proteins - key regulators of anti-viral responses, inflammation, and tumorigenesis in the liverBone specific immunity and its impact on metastasisInducible, dose-adjustable and time-restricted reconstitution of STAT1 deficiency in vivoConditional Stat1 ablation reveals the importance of interferon signaling for immunity to Listeria monocytogenes infectionNatural killer cells in human cancer: from biological functions to clinical applicationsInterferon Gamma: Influence on Neural Stem Cell Function in Neurodegenerative and Neuroinflammatory DiseaseTargeting microenvironment in cancer therapeuticsThe Janus Face of Death Receptor Signaling during Tumor ImmunoeditingThe concept of immune surveillance against tumors. The first theoriesCancers Related to Immunodeficiencies: Update and PerspectivesThe Role of Myeloid-Derived Suppressor Cells (MDSC) in Cancer ProgressionEnhancing the discovery and development of immunotherapies for cancer using quantitative and systems pharmacology: Interleukin-12 as a case studyThe exposome concept in a human nutrigenomics study: evaluating the impact of exposure to a complex mixture of phytochemicals using transcriptomics signaturesPutting tumours in contextType I interferon is selectively required by dendritic cells for immune rejection of tumorsConstitutive type I interferon modulates homeostatic balance through tonic signalingA completely foreign receptor can mediate an interferon-gamma-like response.
P2860
Q4649475-C502FEAA-6E40-43B7-8134-5C0689D273DDQ52392355-BAEE2958-A117-4ED4-AC8F-CA65A7B7230CQ54808426-8316515F-3724-4ECD-A4E2-3D74744EAD40Q54953693-ED1CAD77-F114-4928-BF84-6E5F4668E01EQ54953694-22E4FC24-F169-4359-B8F7-D2DCC4CF47B4Q54953695-30F0BF3F-D42C-4A0B-836C-766516AF97BFQ54953697-0E7893C5-97A3-46C0-A203-D1AED44262CDQ54953702-B9DC57A2-8EFA-45C5-895B-46A8E79E287BQ54953703-008A5970-269C-489F-9C76-FB18D2A166AAQ54953706-386CFF9E-64BC-4B6F-A09F-7DC476436E89Q54953709-FCCB5647-6BC0-434A-A177-AD48D2EA0A96Q54953710-97A6E39D-A5B4-4E24-8912-C1A681358A59Q54953731-4ECE31B7-743E-403F-A715-FD74642255B5Q54953736-4ECF1E82-8F45-41BB-94ED-722F04972039Q54953739-981BDC3E-F17E-41F3-BDF6-4C25E59E1424
P1343
Q22254731-94B1E620-958D-4A37-AEBF-69677EE78951Q24295011-32078863-8AF7-4BFA-9911-6FB2C3C104D1Q24309232-A9B65E79-AEE2-4EEC-B1B2-FBC6C7818952Q24338667-25BE1FDF-8723-460F-9C19-62954074ACE6Q24551158-37988CE3-2E40-45AB-A409-987C558251AAQ24556669-4DCB5AA3-C2B5-49EA-B820-B397D3A58649Q24559982-D0113D7F-9279-4866-A0BB-5DDBD185D945Q24563456-CC137E8F-2EAE-4B71-8245-A1D1B62FAC42Q24634128-3F3A1A8A-3D2C-4649-B316-242BAC4ED867Q24634431-C4F47F00-EAAA-41D4-9DE5-5C55E89005D5Q24643507-B14D0530-D803-48C0-BD07-35B6F6ACE04AQ24655415-EEA0B9D8-23D7-41C7-A42A-7308BAE47BEFQ24679086-F9C5AEC5-C1FA-44B2-B53B-1475079841B9Q24793150-512A35A7-0F4D-4150-97B6-7C4AC5DD65EBQ24793404-24818A61-A074-49B6-B811-61D2F213D450Q24799074-139B99F3-8A47-4362-92D8-FA393B6C66BCQ24805285-15B84F9A-E472-4177-B1B8-E53053455D41Q24806655-58000AD6-1A58-4A98-B10A-9741211EAC3CQ26751472-9E2E12A5-9CDB-4FB2-AAE1-B2B2708A4FEFQ26769884-9C87B9FF-50AB-48C5-8D58-7BD85E989E92Q26799117-22A62ADD-49E1-4DD9-B95D-FEC4C7C732B3Q26821986-F0C35E8B-A393-415D-9F35-AC0779FB644FQ26865509-105290E1-6585-41F5-A349-B011981B3EE4Q27000742-1945B372-E0ED-4A6A-9781-E994A7D9A128Q27022883-EBE4D23A-718D-4A10-A1CA-BFF3EB5E845DQ27330038-88165632-A1C5-4F15-85A1-086B286DC52CQ27345078-C8768940-F47F-4599-A06C-B1596B37F9DFQ27691427-2A7C0160-C031-4419-AE32-0A909A6B1354Q27928023-6C25E9C2-B586-47ED-B1E9-C3F0E2ECF1C9Q28067219-DC465351-3BCB-4E20-B30B-615459431346Q28070036-A4F67AFA-19AD-4F5C-B111-6021C8645F94Q28073937-75A79DF7-2B76-483D-A823-E8BD063C2108Q28074182-0AFFA5DD-82CE-41CA-9262-6A0E5DCEFBA5Q28076760-E48B1D10-BB98-4767-B9D6-9EB543F14FEAQ28084489-60C890FA-08BD-4827-B337-3E66C53FDB67Q28085710-4E9DC13A-E196-4675-99BE-F3243D1A1B38Q28207789-E520C6B4-325A-4B61-92CA-7FC345BFD37CQ28248500-7D501ADD-A156-4089-9BA6-53A9BBB78A2EQ28260631-01F7C52E-82CF-426E-B73B-0C9E00702D13Q28360432-AB66C578-F762-4E36-A058-9F5CD72618BF
P2860
Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh
1998年學術文章
@zh-hant
name
Demonstration of an interferon ...... ystem in immunocompetent mice.
@ast
Demonstration of an interferon ...... ystem in immunocompetent mice.
@en
type
label
Demonstration of an interferon ...... ystem in immunocompetent mice.
@ast
Demonstration of an interferon ...... ystem in immunocompetent mice.
@en
prefLabel
Demonstration of an interferon ...... ystem in immunocompetent mice.
@ast
Demonstration of an interferon ...... ystem in immunocompetent mice.
@en
P2093
P2860
P4510
P356
P1476
Demonstration of an interferon ...... ystem in immunocompetent mice.
@en
P2093
D H Kaplan
E Stockert
R D Schreiber
V Shankaran
P2860
P304
P356
10.1073/PNAS.95.13.7556
P407
P577
1998-06-01T00:00:00Z